Ketamine’s rapid impact on depression linked to immune system pathways

FHS
April 15, 2024
11:18 pm

Study reveals ketamine’s potent anti-inflammatory effects on neurological disorders, showing promise for treating major depressive disorder through modulation of neuroimmune pathways.

Digital Transformation in Healthcare: Why EAM is the Missing Piece

Syed Ali, Founder and CEO of EZO The sector that is perhaps the most critical candidate for digital transformation is the healthcare sector – the

June 27, 2024

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

A China-developed KRAS inhibitor led to objective responses in half of patients with previously treated KRAS-mutant non-small cell lung cancer (NSCLC), a prospective non-randomized trial

June 12, 2024

Tim Schlidt is Funding a New Paradigm in Wellbeing | Psychedelic Invest Podcast

March 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.